SciSparc Receives Nasdaq Non-Compliance Notice for Minimum Stockholders' Equity
summarizeZusammenfassung
SciSparc Ltd. has received a notification from Nasdaq indicating non-compliance with the minimum stockholders' equity requirement, reporting a negative equity balance of approximately $(81,000) as of June 30, 2025, significantly below the $2.5 million threshold. This notice highlights severe financial distress and poses a material risk to the company's Nasdaq listing if not resolved. While the company expects to regain compliance by December 31, 2025, through recent financing activities, investors should closely monitor the situation as failure to meet Nasdaq's requirements could lead to delisting.
check_boxSchlusselereignisse
-
Nasdaq Non-Compliance Notification
SciSparc Ltd. received a notification from Nasdaq for failing to meet the minimum $2.5 million stockholders' equity requirement, reporting approximately $(81,000) as of June 30, 2025.
-
Compliance Plan Deadline
The company has 45 calendar days, until February 26, 2026, to submit a plan to regain compliance with Nasdaq's listing rules.
-
Expected Resolution
SciSparc anticipates regaining compliance by December 31, 2025, citing proceeds from a $4.2 million debenture conversion in August 2025 and a registered direct offering in November 2025.
auto_awesomeAnalyse
SciSparc Ltd. has received a notification from Nasdaq indicating non-compliance with the minimum stockholders' equity requirement, reporting a negative equity balance of approximately $(81,000) as of June 30, 2025, significantly below the $2.5 million threshold. This notice highlights severe financial distress and poses a material risk to the company's Nasdaq listing if not resolved. While the company expects to regain compliance by December 31, 2025, through recent financing activities, investors should closely monitor the situation as failure to meet Nasdaq's requirements could lead to delisting.
Zum Zeitpunkt dieser Einreichung wurde SPRC bei 1,45 $ gehandelt an der NASDAQ im Sektor Life Sciences, bei einer Marktkapitalisierung von rund 4,8 Mio. $. Die 52-Wochen-Handelsspanne lag zwischen 1,25 $ und 19,09 $. Diese Einreichung wurde mit negativer Marktstimmung und einem Wichtigkeitsscore von 8 von 10 bewertet.